Rosacea

Dermatology
5
Pipeline Programs
4
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
2
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Bausch Health
Bausch HealthQUEBEC, Quebec, Canada
1 program
1
vehicle gelPhase 31 trial
Active Trials
NCT01125930TerminatedEst. Jan 2013
CAGE Bio
CAGE BioCA - San Carlos
3 programs
2
1
CGB-400Phase 21 trial
CGB-400Phase 11 trial
CGB-400Phase 11 trial
Active Trials
NCT04508205CompletedEst. Apr 2019
NCT04508660CompletedEst. Apr 2019
NCT04886739CompletedEst. Dec 2021
Precision BioSciences
1 program
1
PDI-320Phase 21 trial
Active Trials
NCT01828177Unknown200Est. Jun 2014
Bayer
BayerLEVERKUSEN, Germany
1 program
Azelaic AcidN/A1 trial
Active Trials
NCT03193372Completed2,200Est. Nov 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Bausch Healthvehicle gel
CAGE BioCGB-400
Precision BioSciencesPDI-320
CAGE BioCGB-400
CAGE BioCGB-400
BayerAzelaic Acid

Clinical Trials (6)

Total enrollment: 2,400 patients across 6 trials

NCT01125930Bausch Healthvehicle gel

Atralin Gel for the Treatment of Rosacea

Start: May 2010Est. completion: Jan 2013
Phase 3Terminated
NCT04886739CAGE BioCGB-400

CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea

Start: May 2021Est. completion: Dec 2021
Phase 2Completed
NCT01828177Precision BioSciencesPDI-320

An Evaluation of PDI-320 in Comparison to Its Monads in Adults With Rosacea

Start: Jun 2013Est. completion: Jun 2014200 patients
Phase 2Unknown
NCT04508205CAGE BioCGB-400

CGB-400 for the Reduction of Facial Redness and Bumps and Blemishes

Start: Oct 2018Est. completion: Apr 2019
Phase 1Completed
NCT04508660CAGE BioCGB-400

CGB-400 for the Reduction of Facial Redness

Start: Oct 2018Est. completion: Apr 2019
Phase 1Completed
NCT03193372BayerAzelaic Acid

A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea

Start: Jul 2017Est. completion: Nov 20172,200 patients
N/ACompleted

Related Jobs in Dermatology

MSL/Senior MSL, Dermatology - Tampa, Florida

AbbVie
Remote
6h ago

(Senior) Außendienstmitarbeiter Dermatology (all genders) - Region Thüringen

AbbVie
Remote
6h ago

(Senior) Außendienstmitarbeiter Dermatology (all genders) - Region Thüringen

AbbVie
Remote
6h ago

Regional Sales Trainer - Dermatology (Central / West Regions)

AbbVie
Remote
7h ago

Regional Sales Trainer - Dermatology (Northeast / Southeast Regions)

AbbVie
Remote
7h ago

Delegado Especialista Ventas Dermatología (Inmunología)

AbbVie
Remote
11h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
4 companies competing in this space

Related Indications

Dermatitis, Atopic(42)Hidradenitis Suppurativa(30)Chronic Spontaneous Urticaria(21)Alopecia Areata(17)Hidradenitis Suppurativa (HS)(10)Vitiligo(9)Chronic Urticaria(5)Pruritus(5)Androgenetic Alopecia(5)Uremic Pruritus(5)